In this episode, Colby and Alin explore the rapidly evolving world of xenotransplantation and what it could mean for patients facing long transplant waitlists. From genetically modified pig organs to early clinical experiences, they discuss the science driving this field forward, the ethical and immunologic challenges that remain, and whether xenotransplantation may serve as a bridge—or an alternative—to traditional human organ donation. Drawing on real-world transplant experience, Colby and ...
All content for Both Sides of the Stethoscope is the property of Colby Salerno, Alin Gragossian and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, Colby and Alin explore the rapidly evolving world of xenotransplantation and what it could mean for patients facing long transplant waitlists. From genetically modified pig organs to early clinical experiences, they discuss the science driving this field forward, the ethical and immunologic challenges that remain, and whether xenotransplantation may serve as a bridge—or an alternative—to traditional human organ donation. Drawing on real-world transplant experience, Colby and ...
Heart Failure Gadgets and more with Dr. Philip Adamson, Chief Medical Officer at Abbott
Both Sides of the Stethoscope
40 minutes
1 year ago
Heart Failure Gadgets and more with Dr. Philip Adamson, Chief Medical Officer at Abbott
In this episode Alin and Colby have an insightful conversation with Dr. Philip Adamson. Phil Adamson is Divisional Vice President and Chief Medical Officer for the Heart Failure Division at Abbott. In this capacity, Dr. Adamson is responsible for global development of Abbott’s heart failure formulary spanning cardiac resynchronization therapy to the CardioMEMS HF system. They discuss the different devices available to help heart failure patients, the progress that has been made over the last ...
Both Sides of the Stethoscope
In this episode, Colby and Alin explore the rapidly evolving world of xenotransplantation and what it could mean for patients facing long transplant waitlists. From genetically modified pig organs to early clinical experiences, they discuss the science driving this field forward, the ethical and immunologic challenges that remain, and whether xenotransplantation may serve as a bridge—or an alternative—to traditional human organ donation. Drawing on real-world transplant experience, Colby and ...
